Financial comparisons GlaxoSmithKline Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. Other stock markets 04:31:15 2026-07-02 EDT			5-day change	1st Jan Change
2,406.90 ^INR	-2.29%		+2.04%	-2.59%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	408M	27.11%	32.52%	49.11%	-	-
ELI LILLY AND COMPANY	65.18B	31.67%	41.84%	106.69%	22.77%	1.2x
JOHNSON & JOHNSON	94.19B	28.46%	32.23%	31.68%	13.82%	0.84x
ABBVIE INC.	61.16B	6.91%	38.79%	64,669.09%	13.22%	2.44x
ROCHE HOLDING AG	77.58B	20.94%	35.49%	47.65%	15.43%	0.66x
ASTRAZENECA PLC	58.74B	17.41%	31.46%	31.99%	13.12%	1.2x
NOVARTIS AG	56.67B	24.64%	38.62%	38.4%	16.33%	1.02x
NOVO NORDISK A/S	48.59B	33.14%	41.3%	60.7%	20.31%	0.69x
AMGEN INC.	36.75B	20.98%	44.09%	162.88%	12.98%	2.13x
GILEAD SCIENCES, INC.	29.44B	28.9%	44.81%	48.87%	17.34%	1.08x
PFIZER INC.	62.58B	12.42%	35.11%	21.07%	8.73%	1.79x
VERTEX PHARMACEUTICALS INCORPORATED	12B	32.94%	43.85%	27.07%	16.41%	-1.21x
BRISTOL-MYERS SQUIBB COMPANY	48.19B	14.64%	30.37%	72.08%	7.72%	1.83x
GSK PLC	43.97B	17.5%	29.95%	46.39%	9.48%	1.28x
SANOFI	51.22B	17.91%	27.85%	10.5%	6.02%	0.81x
CHUGAI PHARMACEUTICAL CO., LTD.	8.02B	34.5%	47.6%	22.1%	25.56%	-0.66x
BAYER AG	53.51B	-7.94%	11.21%	16.66%	-3.36%	4.79x
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	4.52B	24.38%	28.42%	14.26%	12.85%	-4.14x
TAKEDA PHARMACEUTICAL COMPANY LIMITED	28.34B	4.26%	9.07%	-2.1%	1.29%	-3.38x
HALEON PLC	14.85B	15.11%	22.9%	10.23%	4.98%	2.56x
Average	42.8B	20.29%	33.37%	3,274.27%	12.37%	0.79x
Weighted average by Cap.	59.8B	23.48%	37.02%	6,520.54%	15.78%	1.11x